Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month.
Bank of America Global Healthcare Conference 2026 May 13, 2026 6:00 PM EDTCompany ParticipantsDevdatt Kurdikar - President, CEO ...
Everyday Health on MSN
My insurance won’t cover GLP-1 drugs. What now?
Explore alternatives to GLP-1 weight loss drugs if insurance won’t cover them, including appeals, discounts, other ...
Hers is a telehealth platform offering GLP-1 weight loss medications. Learn about its costs, pros, cons, and if it's right for you.
Patients don't regain much weight switching from injections to Lilly's weight-loss pill, study finds
Eli Lilly said on Tuesday that patients in a late-stage trial who had been taking an injectable GLP-1 medication for over a ...
Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity ...
Adults with obesity receiving tirzepatide 10 mg or 15 mg may be able to maintain most of their weight loss after switching to ...
People who stop using GLP-1s tend to regain much of the lost weight. Two new studies identify strategies that can help stave this off. Two new clinical trials suggest options for maintaining weight ...
A pair of trial results published in medical journals suggest switching from high-dose injectables to lower doses or pills could help people with obesity keep their weight down over the long term.
The Cut on MSN
The 'skinny shot' relapse problem
Jessica thought she had recovered from anorexia. Then her doctor prescribed her Zepbound.
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results